Journal article
Effects of sodium glucose co-transporter-2 inhibitors by diabetes status and level of albuminuria: a collaborative meta-analysis
- Abstract:
-
Importance: There is uncertainty about the effects of SGLT2 inhibitors (SGLT2i) in certain types of patients with chronic kidney disease (CKD), with international guidelines offering different strengths of recommendation based on diabetes status and urine albumin:creatinine ratio (uACR) of ≥200 mg/g or <200 mg/g.
Objective: To assess the relative and absolute effects of SGLT2i in participants across the full range of efficacy and serious safety ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 165.3KB, Terms of use)
-
- Publisher copy:
- 10.1001/jama.2025.20835
Authors
Contributors
- Publisher:
- American Medical Association
- Journal:
- Journal of the American Medical Association More from this journal
- Volume:
- 335
- Issue:
- 3
- Pages:
- 220-232
- Publication date:
- 2025-11-07
- Acceptance date:
- 2025-10-14
- DOI:
- EISSN:
-
1538-3598
- ISSN:
-
0098-7484
- Language:
-
English
- Keywords:
- Pubs id:
-
2299882
- Local pid:
-
pubs:2299882
- Deposit date:
-
2025-10-15
- ARK identifier:
Terms of use
- Copyright holder:
- American Medical Association
- Copyright date:
- 2025
- Rights statement:
- Copyright © 2025, American Medical Association
- Notes:
- The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record